Repurposing selective PDE5 inhibitors as anti-cancer agents

Bookmark and Share
Published: 5 Jun 2018
Views: 1242
Rating:
Save
Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium

Dr Pantziarka speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about a recent paper, published in ecancermedicalscience, looking at repurposing selective PDE5 inhibitors as anti-cancer agents.